Gabapentin Tablet, Film Coated
Product Images NDC 55154-3357

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 55154-3357). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag Label (B2da7d96 73ad 4f44 8784 160a384a0961 00)

Bag Label (B2da7d96 73ad 4f44 8784 160a384a0961 00)
Gabapentin Tablets, USP 800mg is a film-coated tablet containing Gabapentin USP 800mg for oral use. The package comes with 10 tablets with storage instructions of 20°C to 25°C. Dosage should be as prescribed by a physician after reading the precautionary statements and warnings. For more information, refer to the insert medication guide available at www.majorpharmaceuticals.com. This product is for Institutional Use Only and should be kept out of the reach of children as it is not child-resistant. Distributed by Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, and distributed further by Major® Pharmaceuticals, Livonia, MI 48152 USA, and Cardinal Health, Dublin, OH 43017.*
FDA Label Image

B2da7d96 73ad 4f44 8784 160a384a0961 01

B2da7d96 73ad 4f44 8784 160a384a0961 01
This is a bottle of Gabapentin Tablets, USP. Each bottle contains 10 tablets. Each coated tablet has Gabapentin USP 800 mg. It's used according to the product insert, which should be reviewed for full prescribing information, warnings, and precautions. The medication should be stored at 20°C to 25°C (68°F to 77°F). It is available only with a prescription, and the pharmacist should dispense it with a medication guide. This unit-dose package is not child-resistant and is only intended for institutional use. The dispenser should keep this and all other tablets out of children's reach. It was distributed by Cardinal Health, Dublin, OH 43017. If an insert/MedGuide is required, it may be obtained at www.majorpharmaceuticals.com.*
FDA Label Image

Creatinine Clearance (Gabapentin Fig1)

Creatinine Clearance (Gabapentin Fig1)
This text is a formula for calculating something called "Lt" using a person's age and weight (in kg) multiplied by a factor of 4 and the person's creatinine level (in g). It is mentioned that the creatinine factor for female patients is 0.85. There is not enough context to determine the purpose or meaning of this calculation.*
FDA Label Image

Figure 1 (Gabapentin Fig2)

Figure 1 (Gabapentin Fig2)
This text provides a chart displaying the mean pain scores observed on a weekly basis during Study 1. The chart includes different treatment groups, such as a placebo group and a group receiving 300 mg/day of Gabapentin. The chart is labeled Figure 1 and includes the names of several individuals involved in the study.*
FDA Label Image

Figure 2 (Gabapentin Fig3)

Figure 2 (Gabapentin Fig3)
FDA Label Image

Figure 3 (Gabapentin Fig4)

Figure 3 (Gabapentin Fig4)
FDA Label Image

Figure 4 (Gabapentin Fig5)

Figure 4 (Gabapentin Fig5)
FDA Label Image

Chemical Structure (Gabapentin Str)

Chemical Structure (Gabapentin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.